Shahbaz S, Sharif A, Akhtar B, Mobashar A, Shazly G, Metouekel A
Naunyn Schmiedebergs Arch Pharmacol. 2024; .
PMID: 39715882
DOI: 10.1007/s00210-024-03720-5.
Mazumder R, Ichudaule , Ghosh A, Deb S, Ghosh R
Top Curr Chem (Cham). 2024; 382(3):22.
PMID: 38937401
DOI: 10.1007/s41061-024-00468-7.
Pecoraro C, Terrana F, Panzeca G, Parrino B, Cascioferro S, Diana P
Molecules. 2023; 28(18).
PMID: 37764226
PMC: 10537790.
DOI: 10.3390/molecules28186450.
Uroos M, Javaid A, Bashir A, Tariq J, Khan I, Naz S
RSC Adv. 2022; 12(37):23963-23972.
PMID: 36093243
PMC: 9400593.
DOI: 10.1039/d2ra03774b.
Mahajan N, Koul B, Kaur J, Bishnoi M, Gupta P, Kumar A
Biomed Res Int. 2022; 2022:9504787.
PMID: 36060144
PMC: 9436577.
DOI: 10.1155/2022/9504787.
Antibacterial and antioxidant assay of novel heteroaryl-substituted methane derivatives synthesized via ceric ammonium nitrate (CAN) catalyzed one-pot green approach.
Verma M, Thakur A, Kapil S, Sharma R, Sharma A, Bharti R
Mol Divers. 2022; 27(2):889-900.
PMID: 35781657
DOI: 10.1007/s11030-022-10461-1.
Promising Lead Compounds in the Development of Potential Clinical Drug Candidate for Drug-Resistant Tuberculosis.
Alghamdi S, Rehman S, Shesha N, Faidah H, Khurram M, Ur Rehman S
Molecules. 2020; 25(23).
PMID: 33276545
PMC: 7729780.
DOI: 10.3390/molecules25235685.
2D-QSAR and docking study of a series of coumarin derivatives as inhibitors of CDK (anticancer activity) with an application of the molecular docking method.
Kasmi R, Hadaji E, Chedadi O, El Aissouq A, Bouachrine M, Ouammou A
Heliyon. 2020; 6(8):e04514.
PMID: 32817887
PMC: 7424200.
DOI: 10.1016/j.heliyon.2020.e04514.
seed oil from west Cameroon: Chemical characterization and assessment of its hypolipidemic effect in high-fat diet-induced rats.
Ngakou Takam P, Tonfack Djikeng F, Kuate D, Nouemsi Kengne A, Doungue Tsafack H, Makamwe I
Food Sci Nutr. 2019; 7(11):3751-3758.
PMID: 31763024
PMC: 6848813.
DOI: 10.1002/fsn3.1234.
Extending the Inhibition Profiles of Coumarin-Based Compounds Against Human Carbonic Anhydrases: Synthesis, Biological, and In Silico Evaluation.
Kartsev V, Geronikaki A, Bua S, Nocentini A, Petrou A, Lichitsky B
Molecules. 2019; 24(19).
PMID: 31590289
PMC: 6804193.
DOI: 10.3390/molecules24193580.
Antihyperlipidemic studies of newly synthesized phenolic derivatives: in silico and in vivo approaches.
Aqeel M, Ur-Rahman N, Khan A, Ashraf Z, Latif M, Rafique H
Drug Des Devel Ther. 2018; 12:2443-2453.
PMID: 30127594
PMC: 6089105.
DOI: 10.2147/DDDT.S158554.
Triazole-diindolylmethane conjugates as new antitubercular agents: synthesis, bioevaluation, and molecular docking.
Danne A, Choudhari A, Chakraborty S, Sarkar D, Khedkar V, Shingate B
Medchemcomm. 2018; 9(7):1114-1130.
PMID: 30108999
PMC: 6072531.
DOI: 10.1039/c8md00055g.
Chalcone Derivatives: Promising Starting Points for Drug Design.
Gomes M, Muratov E, Pereira M, Peixoto J, Rosseto L, Cravo P
Molecules. 2017; 22(8).
PMID: 28757583
PMC: 6152227.
DOI: 10.3390/molecules22081210.
Lanthanide(III) complexes are more active inhibitors of the Fenton reaction than pure ligands.
Martin J, Mladenka P, Saso L, Kostova I
Redox Rep. 2015; 21(2):84-9.
PMID: 26193444
PMC: 6837644.
DOI: 10.1179/1351000215Y.0000000031.
Antinociceptive properties of new coumarin derivatives bearing substituted 3,4-dihydro-2H-benzothiazines.
Alipour M, Khoobi M, Emami S, Fallah-Benakohal S, Ghasemi-Niri S, Abdollahi M
Daru. 2014; 22(1):9.
PMID: 24398032
PMC: 4029140.
DOI: 10.1186/2008-2231-22-9.
Discovery of 3,3'-diindolylmethanes as potent antileishmanial agents.
Bharate S, Bharate J, Khan S, Tekwani B, Jacob M, Mudududdla R
Eur J Med Chem. 2013; 63:435-43.
PMID: 23517732
PMC: 3674182.
DOI: 10.1016/j.ejmech.2013.02.024.
